Hormone replacement therapy (HRT) use has nearly doubled since 2017, according to a new study [1].
This increase reflects a shifting landscape in how medical professionals and patients approach menopause and endocrine health. The trend suggests a growing acceptance of HRT as a primary tool for managing symptoms that previously may have been endured without medical intervention.
Dr. Tara Narula, a medical correspondent for ABC News, said the research findings [1] indicate that the prevalence of these treatments has risen sharply over the last several years, marking a departure from previous decades where caution often limited prescriptions.
HRT is typically used to replenish hormones that decline during menopause, helping to alleviate symptoms such as hot flashes, night sweats, and mood swings. While the study highlights the rise in usage, the specific drivers behind the increase—whether due to new clinical guidelines or patient demand—were not detailed in the immediate report.
Medical providers continue to evaluate the balance of risks and benefits associated with long-term hormone use. The nearly twofold increase [1] underscores a broader movement toward personalized medicine in women's health, where treatment is tailored to individual symptom severity and medical history.
As more patients seek these therapies, the medical community is focusing on ensuring that the surge in use is accompanied by rigorous screening and monitoring to maintain patient safety.
“Hormone replacement therapy (HRT) use has nearly doubled since 2017”
The surge in HRT adoption indicates a pivot in public health perceptions regarding menopause management. By moving away from the restrictive prescribing patterns of the early 2000s, the medical community is acknowledging a higher quality of life for patients, though it necessitates a corresponding increase in long-term safety monitoring.
